GAD-7 Anxiety Screening

Evidence‑based screening tool for generalized anxiety disorder. Answer 7 questions to assess anxiety severity.

About the GAD-7

The Generalized Anxiety Disorder 7-item (GAD-7) scale is a validated self-report questionnaire used to screen for generalized anxiety disorder and assess symptom severity. It asks how often you have been bothered by common anxiety symptoms over the past two weeks.

Scoring: Each item is scored 0 (not at all) to 3 (nearly every day). Total score ranges from 0 to 21.

  • 0–4: Minimal anxiety
  • 5–9: Mild anxiety
  • 10–14: Moderate anxiety
  • 15–21: Severe anxiety

Note: This tool is for screening purposes only and does not replace a professional diagnosis. If you are concerned about your mental health, please consult a healthcare provider.

How to use this tool

For each question, select the option that best describes how often you've experienced the symptom over the last 2 weeks.

  1. Read each question carefully.
  2. Choose the response that matches your experience.
  3. Click "Calculate Score" to see your total score and severity level.
  4. Review the clinical recommendations based on your score.

All answers are processed locally – no data is sent to any server.

Frequently Asked Questions

What does my GAD-7 score mean?

The score indicates the severity of anxiety symptoms. Higher scores suggest more severe anxiety. It's a screening tool, not a diagnosis. Scores of 10 or above typically warrant further evaluation.

Is this test accurate?

The GAD-7 has been validated in multiple populations and has high sensitivity and specificity for detecting generalized anxiety disorder. It is widely used in clinical and research settings.

Can I take this test for someone else?

The GAD-7 is designed for self-report. It can be used by a caregiver to report on someone else's symptoms, but the results should be interpreted with caution.

How often should I retake the test?

It can be used to monitor symptoms over time. Many clinicians use it at baseline and then periodically to track treatment response.